MEI Pharma (MEIP)
Add to Watchlists Create an AlertMEIP Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -2.827 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -9.588M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 124.63M |
| Enterprise Value | 98.05M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 4.833 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -2.162M |
| Return on Equity | -123.5% |
MEIP News
- Nasdaq stocks posting largest percentage decreases May 22
- MEI PHARMA, INC. Financials May 17
- 8 Stocks Under $10 Trending Sharply Higher May 14
- 8 Stocks Under $10 Trending Sharply Higher May 14
- MEI PHARMA, INC. Files SEC form 10-Q, Quarterly Report May 8
- MEI Pharma CEO To Present At Needham Healthcare Conference PR Newswire Apr 23
- 5 Health Care Stocks Under $10 Ready to Rip Higher Apr 18
- 5 Health Care Stocks Under $10 Ready to Rip Higher Apr 18
- Stifel Nicolaus Starts MEI Pharma (MEIP) at Buy Street Insider Apr 15
- MEI Pharma initiated with a Buy at Stifel Apr 15
MEIP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MEI Pharma is up 130.6% over the last year vs S&P 500 Total Return up 27.96%, Supernus Pharmaceuticals up 13.88%, and Rigel Pharmaceuticals down 38.25%.
MEIP Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these MEIP related companies
Pro Ratings for MEIP
Pro Report PDF for MEIP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download MEIP Pro Report PDF
Pro Strategies Featuring MEIP
Did MEI Pharma make it into our Pro Portfolio Strategies?
MEIP Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Other MEIP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MEIP | 8.30 | -0.02 | -0.24% | 124.63M |
